1.
Joint Bone Spine
; 76(4): 421-3, 2009 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19457692
RESUMO
A 72-year-old male with a 4-year history of TNFalpha antagonist therapy (infliximab and etanercept) for ankylosing spondylitis was diagnosed with breast cancer. He had a family history of breast cancer. The low incidence and considerable severity of breast cancer in males, genetic risk factors, and potential role for TNFalpha antagonist therapy are discussed.